Literature DB >> 15517359

Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens.

Giuseppe Zamboni1, Jutta Lüttges, Paola Capelli, Luca Frulloni, Giorgio Cavallini, Paolo Pederzoli, Alexander Leins, Daniel Longnecker, Günter Klöppel.   

Abstract

BACKGROUND AND AIMS: Autoimmune pancreatitis seems to be a disease with a heterogeneous appearance. Our intention was to establish key diagnostic criteria, define grades of severity and activity, identify features of potential subtypes and evaluate the diagnostic relevance of biopsy specimens.
METHODS: Histopathological criteria and clinical features were recorded in pancreatic resection specimens from 53 patients who were found to have chronic pancreatitis lacking pseudocysts, calculi, irregular duct dilatations, pancreas divisum and/or duodenal wall inflammation. The severity of the chronic inflammation was graded, and the activity of the acute inflammatory component and the granulocytic epithelial lesion (GEL) were determined. Additionally, pancreatic biopsy specimens from 9 patients with suspected AIP were assessed.
RESULTS: Periductal lymphoplasmacytic infiltration was identified in all cases, followed in order of frequency by periductal fibrosis and venulitis. These changes were absent in 147 pancreatic specimens that showed chronic pancreatitis associated with pseudocysts, calculi, pancreas divisum and/or duodenal wall inflammation. In 90% of the cases, these chronic changes were graded as 3 or 4. In 81%, the inflammatory process resided in the head of the pancreas and involved the common bile duct. GELs were present in 42% of the patients, who had a mean age of 40.5 years, an almost equal male-female ratio and a high coincidence of ulcerative colitis or Crohn's disease. Patients without GELs were older (mean age 64 years), showed a male preponderance, commonly had Sjogren's syndrome and often developed recurrent bile-duct stenosis. Diagnostically relevant lesions were present in two of five wedge biopsy specimens and three of four fine-needle specimens.
CONCLUSIONS: Periductal lymphoplasmacytic infiltration and fibrosis, preferential occurrence in the pancreatic head and venulitis characterize autoimmune pancreatitis. GELs predominantly occur in a subset of patients who are younger, more commonly have ulcerative colitis and Crohn's disease and seem to have fewer recurrences than patients without GELs. Pancreatic biopsy material proved to be a very helpful adjunct for establishing the diagnosis.

Entities:  

Mesh:

Year:  2004        PMID: 15517359     DOI: 10.1007/s00428-004-1140-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  41 in total

1.  Pancreatic ductal morphology and function in primary Sjögren's syndrome.

Authors:  E Lindström; F Lindström; H von Schenck; I Ihse
Journal:  Int J Pancreatol       Date:  1991-02

2.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

3.  Inflammatory pseudotumour (inflammatory myofibroblastic tumour) of the pancreas: a report of six cases associated with obliterative phlebitis.

Authors:  V Wreesmann; C H van Eijck; D C Naus; M L van Velthuysen; J Jeekel; W J Mooi
Journal:  Histopathology       Date:  2001-02       Impact factor: 5.087

Review 4.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

5.  Chronic sclerosing pancreatitis in Sjögren's syndrome: a case report.

Authors:  S Sood; D P Fossard; K Shorrock
Journal:  Pancreas       Date:  1995-05       Impact factor: 3.327

6.  A case of inflammatory pseudotumour of the common bile duct.

Authors:  N Fukushima; M Suzuki; T Abe; M Fukayama
Journal:  Virchows Arch       Date:  1997-09       Impact factor: 4.064

7.  The characteristic appearance of non-alcoholic duct destructive chronic pancreatitis: a report of 2 cases.

Authors:  K A Scully; S C Li; J C Hebert; T D Trainer
Journal:  Arch Pathol Lab Med       Date:  2000-10       Impact factor: 5.534

8.  Idiopathic pancreatitis associated with inflammatory bowel disease.

Authors:  J A Seyrig; R Jian; R Modigliani; D Golfain; C Florent; B Messing; A Bitoun
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

Review 9.  Autoimmune pancreatitis: pathological, clinical, and immunological features.

Authors:  Günter Klöppel; Jutta Lüttges; Matthias Löhr; Giuseppe Zamboni; Daniel Longnecker
Journal:  Pancreas       Date:  2003-07       Impact factor: 3.327

10.  Idiopathic retroperitoneal fibrosis producing common bile duct and pancreatic duct obstruction.

Authors:  I G Renner; G C Ponto; W T Savage; W D Boswell
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

View more
  143 in total

1.  Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis.

Authors:  Shigeyuki Kawa; Kazuichi Okazaki; Kenji Notohara; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-11-16       Impact factor: 7.527

2.  Pancreas: Histological diagnostic criteria for autoimmune pancreatitis.

Authors:  Terumi Kamisawa; Tooru Shimosegawa
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-13       Impact factor: 46.802

3.  Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.

Authors:  John H Stone; Arezou Khosroshahi; Vikram Deshpande; John K C Chan; J Godfrey Heathcote; Rob Aalberse; Atsushi Azumi; Donald B Bloch; William R Brugge; Mollie N Carruthers; Wah Cheuk; Lynn Cornell; Carlos Fernandez-Del Castillo; Judith A Ferry; David Forcione; Günter Klöppel; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Yasufumi Masaki; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant Sahani; Yasuharu Sato; Thomas Smyrk; James R Stone; Masayuki Takahira; Hisanori Umehara; George Webster; Motohisa Yamamoto; Eunhee Yi; Tadashi Yoshino; Giuseppe Zamboni; Yoh Zen; Suresh Chari
Journal:  Arthritis Rheum       Date:  2012-10

4.  Calcifying fibrous pseudotumor affecting the retroperitoneum: could it be a new entity within the spectrum of IgG-4 sclerosing disease?

Authors:  M J Fernández Aceñero; Peter W Vorwald; Sharon Cordova Yamauchi
Journal:  Virchows Arch       Date:  2010-04-23       Impact factor: 4.064

Review 5.  Autoimmune pancreatitis and IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Kensuke Takuma; Naoto Egawa; Koji Tsuruta; Tsuneo Sasaki
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-15       Impact factor: 46.802

Review 6.  IgG₄-related sclerosing disease: a novel mimic of inflammatory bowel disease.

Authors:  Neeraj Narula; Monica Vasudev; John K Marshall
Journal:  Dig Dis Sci       Date:  2010-06-03       Impact factor: 3.199

Review 7.  Autoimmune pancreatitis and IgG4-related systemic diseases.

Authors:  Lizhi Zhang; Thomas C Smyrk
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

8.  Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria.

Authors:  Sönke Detlefsen; Asbjørn Mohr Drewes; Mogens Vyberg; Günter Klöppel
Journal:  Virchows Arch       Date:  2009-02-24       Impact factor: 4.064

9.  An experimental model of autoimmune pancreatitis in the rat.

Authors:  Todd S Davidson; Daniel S Longnecker; William F Hickey
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 10.  Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis.

Authors:  Stefano Crosara; Mirko D'Onofrio; Riccardo De Robertis; Emanuele Demozzi; Stefano Canestrini; Giulia Zamboni; Roberto Pozzi Mucelli
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.